Investors

People are different and so is their cancer, patients should be treated individually.

Ownership Structure

Ownership structure per 30. June 2021

Owner Number of shares Percentage
OT 311 ApS* 4 156 134 24,04
Avanza Pension 1 524 393 8,82
ClearStream Banking 828 469 4,79
SVM Verwal Tungsgesellschaft 792 392 4,58
Grith Hagel 681 708 3,94
Diff För XDB I Ägares Ställe 493 552 2,85
Nordnet Pension 436 965 2,53
Pension Futur 378 629 2,19
Other Shareholders 7 995 274 46,26
Total 17 287 516 100

*OT 311 100 % owned by CSO Ole Thastrup

The Manager Transactions Register can be viewed here: https://marknadssok.fi.se

Upcoming events

September 15, 2021 at 15:00 (CET)

Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.

Read more

September 23, 2021

CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark

Read more and Register

September 28, 2021

Redeye Medtech & Diagnostics Investor meeting

Read more

September 29, 2021

Mangold Investor Lunch

Read more

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.